Aptose Biosciences Inc. (APTO) Operating Lease, Right-of-Use Asset USD 2018 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Aptose Biosciences Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from 2018 to 2024.
  • Aptose Biosciences Inc. Operating Lease, Right-of-Use Asset for the quarter ending March 31, 2024 was $850 K, a 30.2% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $850 K -$368 K -30.2% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $943 K -$354 K -27.3% Dec 31, 2023 10-Q 2024-05-14
Q3 2023 $1.04 M +$815 K +370% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $1.13 M +$795 K +240% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $1.22 M +$776 K +176% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 $1.3 M +$832 K +179% Dec 31, 2022 10-K 2024-03-26
Q3 2022 $220 K -$359 K -62% Sep 30, 2022 10-Q 2022-11-01
Q2 2022 $331 K -$367 K -52.6% Jun 30, 2022 10-Q 2022-08-02
Q1 2022 $442 K -$366 K -45.3% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $465 K -$460 K -49.7% Dec 31, 2021 10-K 2023-03-24
Q3 2021 $579 K -$462 K -44.4% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $698 K -$449 K -39.1% Jun 30, 2021 10-Q 2021-08-03
Q1 2021 $808 K -$454 K -36% Mar 31, 2021 10-Q 2021-05-04
Q4 2020 $925 K -$451 K -32.8% Dec 31, 2020 10-K 2022-03-22
Q3 2020 $1.04 M -$450 K -30.2% Sep 30, 2020 10-Q 2020-11-10
Q2 2020 $1.15 M -$426 K -27.1% Jun 30, 2020 10-Q 2020-08-04
Q1 2020 $1.26 M -$418 K -24.9% Mar 31, 2020 10-Q 2020-05-05
Q4 2019 $1.38 M -$194 K -12.4% Dec 31, 2019 10-K 2021-03-23
Q3 2019 $1.49 M Sep 30, 2019 10-Q 2019-11-05
Q2 2019 $1.57 M Jun 30, 2019 10-Q 2019-08-06
Q1 2019 $1.68 M Mar 31, 2019 10-Q 2019-05-07
Q4 2018 $1.57 M Jan 1, 2019 10-K 2021-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.